Faculty & CME Information

Program Title: Atopy in Asthma: Making the Pieces Fit in Clinical Practice

Estimated Time to Complete the Activity: 1.0 hour

Jointly sponsored by Postgraduate Institute for Medicine, www.pimed.com, Respiratory & Allergic Disease Foundation, and Educational Concepts in Medicine.

This activity is supported by an educational grant from Genentech, Inc., and Novartis Pharmaceuticals Corporation.

Target Audience: This activity has been designed to meet the educational needs of pulmonologists who treat asthma patients as well as nurse practitioners and physician assistants who work in pulmonary care settings across the United States.

Statement of Need: Current asthma guidelines of the National Heart, Lung, and Blood Institute acknowledge allergy and IgE-mediated processes as major contributors to persistent asthma. These guidelines—the Expert Panel Report 3 (EPR-3)—outline specific recommendations for evaluating the potential role of allergy and IgE in patients with asthma. Nevertheless, many office-based pulmonologists underestimate the clinical relevance of these processes to asthma and many do not routinely test or screen their asthma patients for allergies. This educational activity is designed to increase awareness among pulmonologists and their ancillary healthcare staff on the role of IgE-driven processes in asthma and instruct on ways to integrate pertinent EPR-3 guidelines into clinical practice for improved patient outcomes.

Educational Objectives
After completing this activity, the participant should be better able to:

Explain how to incorporate into clinical practice the NAEPP EPR-3 guidelines pertaining to allergy testing and trigger identification in patients with persistent asthma
Explain how to apply case-based learning about allergy and IgE-mediated processes in persistent asthma to real-world clinical practice
Describe the clinical role of IgE and allergy in asthma and their association with negative health outcomes
Choose treatment strategies for managing patients with IgE-mediated asthma

Faculty Presenters
Bradley E. Chipps, MD
Capital Allergy & Respiratory Disease Center
Sutter Medical Center
Sacramento, California

Elliot Israel, MD
Director of Pulmonary Clinical Research
Brigham & Women's Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Stephen C. Lazarus, MD
Professor of Medicine
Chief, Division of Pulmonary and Critical Care Medicine
University of California San Francisco
San Francisco, CA

Richard J. Martin, MD
Chairman and Professor
Department of Medicine
The Edelstein Family Chair in Pulmonary Medicine
National Jewish Medical and Research Center
Denver, Colorado

Richard B. Moss, MD
Professor of Pediatrics
Chief, Allergy-Immunology
Director, Cystic Fibrosis Center
Stanford University School of Medicine
Lucile Packard Children’s Hospital
Palo Alto, California

Dennis R. Ownby, MD
Betty B. Wray Professor of Pediatrics and Professor of Medicine
Head, Section of Allergy and Immunology
Medical College of Georgia
Augusta, Georgia

Stephen P. Peters, MD, PhD
Professor of Medicine and Pediatrics
Associate Director
Center for Human Genomics
Director of Research
Section on Pulmonary,
Critical Care, Allergy & Immunology
Wake Forest University School of Medicine
Winston-Salem, North Carolina

Michael Wechsler, MD, MMSc
Associate Director
Brigham & Women's Asthma Research Center
Assistant Professor of Medicine
Harvard Medical School
Boston, MA

Program Agenda

30-minute Didactic Presentation
15-minute Case Presentation
15-minute Question-and-Answer Session

Physician Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM), the Respiratory & Allergic Disease Foundation (RAD), and Educational Concepts in Medicine. PIM is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

I have read the CME information.

Register Now How to Dial In Download Slides CME Info Contact Us About RAD	Program Title: Atopy in Asthma: Making the Pieces Fit in Clinical Practice Estimated Time to Complete the Activity: 1.0 hour Jointly sponsored by Postgraduate Institute for Medicine, www.pimed.com, Respiratory & Allergic Disease Foundation, and Educational Concepts in Medicine. This activity is supported by an educational grant from Genentech, Inc., and Novartis Pharmaceuticals Corporation. Target Audience: This activity has been designed to meet the educational needs of pulmonologists who treat asthma patients as well as nurse practitioners and physician assistants who work in pulmonary care settings across the United States. Statement of Need: Current asthma guidelines of the National Heart, Lung, and Blood Institute acknowledge allergy and IgE-mediated processes as major contributors to persistent asthma. These guidelines—the Expert Panel Report 3 (EPR-3)—outline specific recommendations for evaluating the potential role of allergy and IgE in patients with asthma. Nevertheless, many office-based pulmonologists underestimate the clinical relevance of these processes to asthma and many do not routinely test or screen their asthma patients for allergies. This educational activity is designed to increase awareness among pulmonologists and their ancillary healthcare staff on the role of IgE-driven processes in asthma and instruct on ways to integrate pertinent EPR-3 guidelines into clinical practice for improved patient outcomes. Educational Objectives After completing this activity, the participant should be better able to: Explain how to incorporate into clinical practice the NAEPP EPR-3 guidelines pertaining to allergy testing and trigger identification in patients with persistent asthma Explain how to apply case-based learning about allergy and IgE-mediated processes in persistent asthma to real-world clinical practice Describe the clinical role of IgE and allergy in asthma and their association with negative health outcomes Choose treatment strategies for managing patients with IgE-mediated asthma Faculty Presenters Bradley E. Chipps, MD Capital Allergy & Respiratory Disease Center Sutter Medical Center Sacramento, California Elliot Israel, MD Director of Pulmonary Clinical Research Brigham & Women's Hospital Associate Professor of Medicine Harvard Medical School Boston, MA Stephen C. Lazarus, MD Professor of Medicine Chief, Division of Pulmonary and Critical Care Medicine University of California San Francisco San Francisco, CA Richard J. Martin, MD Chairman and Professor Department of Medicine The Edelstein Family Chair in Pulmonary Medicine National Jewish Medical and Research Center Denver, Colorado Richard B. Moss, MD Professor of Pediatrics Chief, Allergy-Immunology Director, Cystic Fibrosis Center Stanford University School of Medicine Lucile Packard Children’s Hospital Palo Alto, California Dennis R. Ownby, MD Betty B. Wray Professor of Pediatrics and Professor of Medicine Head, Section of Allergy and Immunology Medical College of Georgia Augusta, Georgia Stephen P. Peters, MD, PhD Professor of Medicine and Pediatrics Associate Director Center for Human Genomics Director of Research Section on Pulmonary, Critical Care, Allergy & Immunology Wake Forest University School of Medicine Winston-Salem, North Carolina Michael Wechsler, MD, MMSc Associate Director Brigham & Women's Asthma Research Center Assistant Professor of Medicine Harvard Medical School Boston, MA Program Agenda 30-minute Didactic Presentation 15-minute Case Presentation 15-minute Question-and-Answer Session Physician Continuing Medical Education Accreditation Statement This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM), the Respiratory & Allergic Disease Foundation (RAD), and Educational Concepts in Medicine. PIM is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Disclosure of Conflicts of Interest Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. I have read the CME information.


	All Rights Reserved. Use of this Web site is governed by the Terms of Use \| Privacy Policy © 2009 RAD Foundation. All rights reserved.